Showing results (91-100 of 107) with videos related to
Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2005
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancerEiichi Sato, Sara H Olson, Jiyoung Ahn, et al.JAMA Network Open|January 16, 2019
Ultrarestrictive Opioid Prescription Protocol for Pain Management After Gynecologic and Abdominal SurgeryJaron Mark, Deanna M Argentieri, Camille A Gutierrez, et al.Gynecologic Oncology|March 14, 2017
A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group studyJanet S Rader, Michael W Sill, Jan H Beumer, et al.Gynecologic Oncology|August 27, 2023
Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 womenIan S Hagemann, Wei Deng, Richard J Zaino, et al.Gynecologic Oncology|January 11, 2021
The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 womenIan S Hagemann, Wei Deng, Richard J Zaino, et al.Gynecologic Oncology|January 6, 2023
Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivorsCynthia A Thomson, Tracy E Crane, Austin Miller, et al.Oncotarget|August 7, 2019
Oncologist uptake of comprehensive genomic profile guided targeted therapyMary K Nesline, Paul DePietro, Grace K Dy, et al.Gynecologic Oncology|January 7, 2025
Prognostic significance of serum complement activation, neutrophil extracellular traps and extracellular DNA in newly diagnosed epithelial ovarian cancerJason Ricciuti, Qian Liu, A N M Nazmul H Khan, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 22, 2013
Ovarian cancer, version 2.2013Robert J Morgan, Ronald D Alvarez, Deborah K Armstrong, et al.BMC Medical Informatics and Decision Making|January 20, 2019
Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencingGrace K Dy, Mary K Nesline, Antonios Papanicolau-Sengos, et al.Pageof 11